PUBLISHER: Grand View Research | PRODUCT CODE: 1790477
PUBLISHER: Grand View Research | PRODUCT CODE: 1790477
The U.S. ferritin testing market size was estimated at USD 274.60 million in 2024 and is projected to grow at a CAGR of 5.63% from 2025 to 2033. The market is driven by the rising prevalence of iron deficiency anemia and related chronic conditions such as inflammatory diseases, chronic kidney disease, and cancer.
Increasing awareness among healthcare professionals about the importance of ferritin as a biomarker for iron storage and inflammation has led to its growing adoption in both routine health screenings and specialized diagnostic protocols. In addition, the expanding geriatric population is more susceptible to anemia and nutritional deficiencies has amplified the demand for ferritin testing in clinical settings.
Millions of women of childbearing age and young children under five are likely suffering from anemia, experiencing symptoms like fatigue, weakness, and shortness of breath. These debilitating effects not only diminish their health and productivity but also have a broader impact on families, communities, and the development of nations. The chart below illustrates the incidence of anemia in the U.S. from 2021 to 2023.
U.S. Ferritin Testing Market Report Segmentation
This report forecasts revenue growth at, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ferritin testing market report based on product, application, technique, test type, end use, and region.